Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Bayer AG
  6. News
  7. Summary
    BAYN   DE000BAY0017


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Bayer : says to appeal U.S. court ruling on PCBs if necessary

07/28/2021 | 05:19am EDT
FILE PHOTO: Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen

FRANKFURT (Reuters) - German chemicals maker Bayer said on Wednesday it may appeal an order in a U.S. legal case to pay $185 million to four staff members of a school in the state of Washington over exposure to polychlorinated biphenyls, or PCBs, made by the former Monsanto Co.

Bayer, which bought Monsanto for $63 billion in 2018, said it disagreed with the verdict and planned to pursue post-trial motions and, if necessary, an appeal.

"The undisputed evidence in this case does not support the conclusions that plaintiffs were exposed to unsafe levels of PCBs at the Sky Valley Education Center (SVEC) or that any exposure could have possibly caused their claimed injuries," Bayer said in a statement.

"In reality, testing reflected extremely low levels of PCBs in this school."

PCBs were once used widely to insulate electrical equipment, and were also used in such products as carbonless copy paper, caulking, floor finish and paint. They were outlawed by the U.S. government in 1979 after being linked to cancer and other health problems. Monsanto produced PCBs from 1935 to 1977.

The plaintiffs had alleged exposure to PCB at the SVEC from fluorescent light ballasts, which Bayer said were produced decades ago by customers of Monsanto's products and installed in the late 1960s.

"These light ballasts were decades beyond their useful life, energy inefficient, and obsolete," Bayer said.

"These are historic claims that relate to products Monsanto has not produced in more than 40 years and are unrelated to any ongoing business of Monsanto, and now Bayer."

In December, a U.S. federal judge rejected Bayer's proposed $648 million settlement of separate class-action litigation by cities and other claimants over waste water contaminated with PCBs made by Monsanto.

Bayer has submitted a revised settlement to the court and is confident that it will be approved, a spokesperson for Bayer said. The company expects a decision on the matter this summer.

(Reporting by Patricia Weiss; Writing by Maria Sheahan; Editing by Douglas Busvine and Jane Merriman)

© Reuters 2021
All news about BAYER AG
09/17BAYER AG : Morgan Stanley maintains a Buy rating
09/16BWX TECHNOLOGIES : BWXT Medical to Collaborate With Bayer on Actinium-225 Radioi..
09/16BAYER : launches transparency register for scientific collaborations with extern..
09/16BAYER : Reports 'Sustained Clinical Benefit' From New Studies on Vitrakvi Cancer..
09/16BAYER : Latest analyses of Vitrakvi (larotrectinib) reaffirm powerful efficacy a..
09/15BAYER AG : Credit Suisse sticks Neutral
09/15PRESS RELEASE : Tele Columbus AG: Eisenbahner-Wohnungsbaugenossenschaft (EWG) an..
09/15Deutsche Bank Eyes External Candidates for Chairman
09/14BAYER : Unit Co-Leads $15 Million Funding Round for US-Based Biotechnology Group
09/14BAYER : Andes Raises USD 15 Million in Series A Funding Co-Led by Leaps by Bayer..
More news
Analyst Recommendations on BAYER AG
More recommendations
Sales 2021 42 596 M 49 944 M 49 944 M
Net income 2021 860 M 1 009 M 1 009 M
Net Debt 2021 39 369 M 46 160 M 46 160 M
P/E ratio 2021 31,9x
Yield 2021 4,51%
Capitalization 44 415 M 52 137 M 52 077 M
EV / Sales 2021 1,97x
EV / Sales 2022 1,88x
Nbr of Employees 99 439
Free-Float 100,0%
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | MarketScreener
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 45,21 €
Average target price 62,45 €
Spread / Average Target 38,1%
EPS Revisions
Managers and Directors
Werner Baumann Chairman-Management Board & CEO
Wolfgang U. Nickl Chief Financial Officer
Norbert Winkeljohann Chairman-Supervisory Board
Bijoy Sagar Chief Information Technology Officer
Paul Achleitner Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BAYER AG-6.12%52 137
JOHNSON & JOHNSON4.68%434 939
ROCHE HOLDING AG11.70%327 062
PFIZER, INC.20.81%249 329
NOVO NORDISK A/S51.34%233 887